Carter Eric G has filed 8 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 308641 shares of AEON Biopharma, Inc. ($AEON) on May 21, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Not found | A | Restricted Stock Units | 308641 | $0.00 | 308,641.0000 | 3,984,876 | 9999.99% | 7.75% |
| Aug. 31, 2024 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Director | A | Class A Common Stock | 36021 | $0.00 | 36,021.0000 | 539,840 | 9999.99% | 6.67% |
| Aug. 31, 2024 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Director | A | Stock Option | 96210 | $0.00 | 96,210.0000 | 539,840 | 9999.99% | 17.82% |
| March 19, 2024 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Director | A | Stock Option | 16260 | $0.00 | 16,260.0000 | 516,404 | 9999.99% | 3.15% |
| March 19, 2024 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Director | A | Stock Option | 8130 | $0.00 | 8,130.0000 | 516,404 | 9999.99% | 1.57% |
| Aug. 14, 2023 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Director | A | Stock Option | 58851 | $0.00 | 58,851.0000 | 138,848,177 | 9999.99% | 0.04% |
| July 21, 2023 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Director | A | Stock Option | 9007 | $0.00 | 9,007.0000 | 138,825,356 | 9999.99% | 0.01% |
| July 21, 2023 | AEON Biopharma, Inc. | $AEON | Carter Eric G | Director | A | Stock Option | 11802 | $0.00 | 11,802.0000 | 138,825,356 | 9999.99% | 0.01% |